Allan H. Young, MBChB, MPhil, PhD, MRCPsych

Esketamine Nasal Spray Plus for Depression

April 28, 2020

Read a study about esketamine nasal spray (oral antidepressant) and it's long-term safety, tolerability, and efficacy for treatment-resistant depression (TRD).

Ewa Wajs , Leah Aluisio , Richard Holder , et al

Original Research

Bridging the Gap Between Mixed and Atypical Depression

February 19, 2019

Is there a common denominator between mixed depression and atypical depressive features? In this post hoc analysis of the BRIDGE-II-MIX Study, affective lability and mood reactivity were investigated in...

Norma Verdolini , Giulia Menculini , Giulio Perugi , et al

Original Research

Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study

March 25, 2015

Giulio Perugi , Jules Angst , Jean-Michel Azorin , et al

Original Research

Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients

March 9, 2010

Ric M. Procyshyn , William G. Honer , Tony K. Y. Wu , et al

Original Research

Quetiapine vs Lithium for Bipolar

January 26, 2010

Read a study comparing the efficacy and tolerability of quetiapine and lithium monotherapy with a placebo for a major depressive episode in bipolar disorder.

Allan H. Young , Susan L. McElroy , Michael Bauer , et al

Original Research

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

January 26, 2010

Susan L. McElroy , Richard H. Weisler , William Chang , et al

Educational Activity

Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities

August 15, 2009

Many patients with bipolar disorder are initially misdiagnosed. Clinicians may incorrectly diagnose bipolar disorder as unipolar depression, borderline personality disorder, schizophrenia, anxiety, or substance use disorder. The consequences of...

Allan H. Young

Academic Highlights

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

October 31, 2008

Siegfried Kasper , Joseph R. Calabrese , Gordon Johnson , et al

Article

Treatment of Bipolar Disorder With Antipsychotic Medication: Issues Shared With Schizophrenia

June 15, 2007

Allan H. Young

Educational Activity

The Art and Science of Switching of Antipsychotic Medications, Part 1

November 15, 2006

Peter J. Weiden , Allan H. Young , Peter F. Buckley

Letter to the Editor

Dr. Macking and Young Reply

May 15, 2006

Paul Mackin , Allan H. Young

Original Research

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

November 15, 2005

Paul Mackin , Allan H. Young

Allan H. Young, MBChB, MPhil, PhD, MRCPsych

Esketamine Nasal Spray Plus for Depression

Bridging the Gap Between Mixed and Atypical Depression

Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study

Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients

Quetiapine vs Lithium for Bipolar

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

Treatment of Bipolar Disorder With Antipsychotic Medication: Issues Shared With Schizophrenia

The Art and Science of Switching of Antipsychotic Medications, Part 1

Dr. Macking and Young Reply

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

ELSEWHERE:

FOLLOW US:

Allan H. Young, MBChB, MPhil, PhD, MRCPsych

Esketamine Nasal Spray Plus for Depression

Bridging the Gap Between Mixed and Atypical Depression

Mixed Features in Patients With a Major Depressive Episode: the BRIDGE-II-MIX Study

Persistent Antipsychotic Polypharmacy and Excessive Dosing in the Community Psychiatric Treatment Setting: A Review of Medication Profiles in 435 Canadian Outpatients

Quetiapine vs Lithium for Bipolar

A Double-Blind, Placebo-Controlled Study of Quetiapine and Paroxetine as Monotherapy in Adults With Bipolar Depression (EMBOLDEN II)

Bipolar Disorder: Diagnostic Conundrums and Associated Comorbidities

International Consensus Group on the Evidence-Based Pharmacologic Treatment of Bipolar I and II Depression

Treatment of Bipolar Disorder With Antipsychotic Medication: Issues Shared With Schizophrenia

The Art and Science of Switching of Antipsychotic Medications, Part 1

Dr. Macking and Young Reply

QTc Interval Measurement and Metabolic Parameters in Psychiatric Patients Taking Typical or Atypical Antipsychotic Drugs: A Preliminary Study

Watch the New PsychCase360

Subscribe to readmore articles

Subscribe to read
more articles